The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B

CompletedOBSERVATIONAL
Enrollment

304

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Hemophilia
Interventions
OTHER

Blood sample

Blood withdrawal.

OTHER

Questionnaire

Online questionnaire about the bleeds that patients experienced in the past.

OTHER

MRI-imaging

MRI imaging of joints.

OTHER

Physical examination

Physical examination of joint status.

Trial Locations (17)

Unknown

Royal Adelaide Hospital, Adelaide

Medical University of Vienna, Vienna

Multicentre: Leuven, Brussels, Multiple Locations

Multicentre: Vancouver, Toronto, Hamilton, Multiple Locations

Helsinki University Central Hospital, Helsinki

Multicentre: Bonn, Berlin, Frankfurt, München, Hamburg, Multiple Locations

Multicentre: Florence, Rome, Parma, Milan, Turin, Multiple Locations

Academic Medical Center, Amsterdam

University Medical Center Groningen, Groningen

Leiden University Medical Center, Leiden

Maastricht University Medical Center, Maastricht

Radboud University Medical Center, Nijmegen

Erasmus Medical Center, Rotterdam

Utrecht University Medical Center, Utrecht

Máxima Medical Center, Veldhoven

Multicentre: Valencia, Madrid, Barcelona, Multiple Locations

Multicentre: Manchester, London, Liverpool, Glasgow, Cardiff, Sheffield, Multiple Locations

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT03623295 - The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B | Biotech Hunter | Biotech Hunter